Back to Safety topics

Surveillance and antimicrobials

Direct medical costs of healthcare-associated infections, March 2009

This report by medical economist RD Scott II uses results from the published medical and economic literature to provide a range of estimates for the annual direct medical hospital cost of treating healthcare-associated infections (HAIs) in the United States. This document is also available on CDC's Infection Control in Healthcare Settings page;
Go to: http://www.cdc.gov/ncidod/dhqp/index.html

Antimicrobial-Resistant pathogens associated with healthcare-associated infections report, 2008

Antimicrobial-Resistant pathogens associated with healthcare-associated infections report - 2008 Annual summary of data reported to the NHSN at CDC, 2006–2007 Describes the scope and magnitude of select antimicrobial-resistant pathogens among infections reported to the device-and procedure-associated modules of the NHSN, Infect Control Hosp Epidemiol 2008; 29:996-1011.

Active Surveillance - MRSA and VRE
SHEA-APIC Position paper, 2007

Legislative Mandates for Use of Active Surveillance Cultures to Screen for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci: Position Statement from the Joint SHEA and APIC Task Force, 2007. Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, Olmsted RN, Marc Bonten M, Lundstrom T, Climo MW, Roghmann MC, Murphy CL, Karchmer, TL.

Back to top

CDC Healthcare-associated infections and
mortality, 2007

CDC published a national estimate of the number of healthcare-associated infections (HAI) and deaths in the United States in the March-April edition of Public Health “Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002.” The authors concluded that the method they used for estimating the number of HAIs made the best use of existing national data. Data from the National Nosocomial Infections Surveillance (NNIS) System (1990 – 2002), the National Discharge Survey (2002), and the American Hospital Association Survey (2000) was used. Study findings are summarized in a PowerPoint presentation

Back to topp

Prevention - antimicrobial resistance – hospitals, 1997

Guidelines for the prevention of antimicrobial resistance in hospitals,1997
Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL Duncan, RA, Eckman MR,Ferrer WE, Greene WH, Lorian V, Levey S, McGowan JE Jr,Paul SM, Ruskin J, Tenover GC, Watanakunakorn C, Society for Healthcare Epidemiology of America and Infectious Disease Society of America Joint Committee on the Prevention of Antimicrobial Resistance. Infect Control Hosp Epidemiol 1997; 18(4):275-91.

Back to top

Resistance report - ICARE ICU, 1999

Selected antimicrobial resistant pathogens associated with nosocomial infections in ICU patients, 1999. Current information is maintained by Emory University.
Go to http://www.sph.emory.edu/ICARE/

Back to top

Surveillance – antimicrobials - ICARE, 1999

Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, 1999
Data summary from January 1996 through December 1997: A report from the National Nosocomial Infections Surveillance (NNIS) System. American Journal of Infection Control 1999 Jun;27(3):279-84. Current information is maintained by Emory University. Go to http://www.sph.emory.edu/ICARE/

Back to top

Business case for preventing healthcare-associated infections, 2007

Dispelling the Myths: The True Cost of Healthcare-Associated Infections, 2007
Murphy D, and Whiting J. February, 2007. The Association for Professional in Infection Control and Epidemiology (APIC) has released a white paper on healthcare associated infections (HAI) titled "Dispelling the Myths: The True Cost of Healthcare-Associated Infections."

Back to top

Home | Reducing Costs | Improving Quality & Safety | Managing Risk | About Premier